{
    "code": "60001033",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001033",
    "time": "2021-04-17 02:16:27",
    "許可證字號": "衛部菌疫輸字第001033號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/12\/02",
    "發證日期": "105\/12\/02",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000103302",
    "中文品名": "瑞百安注射液",
    "英文品名": "Repatha Solution for Injection",
    "適應症": "1. 預防心血管事件：對於已確診心血管疾病的成年病人，REPATHA可用於降低心肌梗塞、中風及冠狀動脈血管重建術的風險。\r\n2. 原發性高脂血症（包含異合子家族性高膽固醇血症）：REPATHA可單獨使用或併用其他降血脂藥物（例如：statin類藥物、ezetimibe），作為飲食外的輔助治療以降低原發性高脂血症成人病人之低密度脂蛋白膽固醇 (LDL-C)。",
    "劑型": "279注射液",
    "包裝": "1mL預填針筒 1mL預填SureClick自動注射器",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/12\/02",
    "主成分略述": "Evolocumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "620117N253  台灣安進藥品有限公司",
    "申請商地址": "臺北市信義區松仁路100號13樓之1、之2",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0034000  AMGEN MANUFACTURING,LIMITED",
            "製造廠廠址": "STATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060",
            "製造廠公司地址": "",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FUS0866000  IMMUNEX RHODE ISLAND CORPORATION",
            "製造廠廠址": "40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406004500",
            "成分名稱": "Evolocumab",
            "含量描述": "",
            "含量": "140.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Repatha HLD_20170330_AI 4-106-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=004&Type=10"
        },
        {
            "title": "Repatha HLD_20170330_AI 3-106-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=003&Type=10"
        },
        {
            "title": "Repatha HLD_20170330_AI 2-106-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=002&Type=10"
        },
        {
            "title": "Repatha HLD_20170330_AI 1-106-03-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Repatha Solution for Injection_中文仿單-108-04-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=004&Type=9"
        },
        {
            "title": "衛部菌疫輸字第001033號_瑞百安注射液_中文仿單-106-11-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=013&Type=8"
        },
        {
            "title": "Repatha HLD_20170330_carton 7-106-03-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=012&Type=8"
        },
        {
            "title": "020010330005 TWEB PFS-106-01-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001033&Seq=005&Type=8"
        }
    ]
}